封面
市場調查報告書
商品編碼
1452837

全球濕性傷口敷料市場規模、佔有率和成長分析:按產品、應用和最終用戶 - 產業預測(2024-2031)

Global Moist Wound Dressings Market Size, Share, Growth Analysis, By Product(Foams, Hydrocolloids), By Application(Pressure Ulcers, Diabetic Ulcers), By End-user(Hospitals, Homecare) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球濕性傷口敷料市場規模預計2022年為43.1億美元,從2023年的45.3億美元成長到2031年的68億美元,預計將從2023年的45.3億美元成長到2031年的68億美元。2031 億美元)複合年成長率為5.2%。

由於對先進創傷護理的日益關注以及糖尿病潰瘍和壓瘡等慢性傷口數量的迅速增加,全球濕性傷口敷料市場呈現強勁成長。濕性傷口敷料擴大被醫療保健專業人員採用,因為它們可以促進最佳的癒合環境、預防感染並加速傷口癒合。這些敷料具有增強保濕性、減少疼痛和提高患者舒適度等優點。此外,研究和開發不斷透過創新材料和技術提高濕性傷口敷料的有效性。隨著全球人口老化的不斷加劇和醫療保健基礎設施的進步,對高效傷口管理解決方案的需求預計將在短期內推動市場成長。

目錄

執行摘要

  • 市場概況
  • 命運之輪

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模估算
  • 市場假設與限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管環境
  • 波特的分析
  • 對未來中斷的特殊考慮

全球濕潤傷口敷料市場:依產品

  • 市場概況
  • 形式
  • 親水膠體
  • 半透膜
  • 水凝膠
  • 藻酸鹽
  • 親水性纖維敷料膠原蛋白

全球濕性傷口敷料市場:依應用分類

  • 市場概況
  • 褥瘡
  • 糖尿病潰瘍
  • 燒燙傷
  • 手術傷口
  • 外傷
  • 其他

全球濕潤傷口敷料市場:依最終用戶分類

  • 市場概況
  • 醫院
  • 居家護理
  • 診所
  • 其他

全球濕性傷口敷料市場規模(按地區分類)

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2021年)
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率(2021年)

主要企業簡介

  • 3M Healthcare(US)
  • Coloplast A/S(Denmark)
  • Medline Industries, Inc.(US)
  • Cardinal Health, Inc.(US)
  • B. Braun Melsungen AG(Germany)
  • Smith & Nephew PLC(UK)
  • ConvaTec Group PLC(UK)
  • Derma Sciences, Inc.(US)
  • Systagenix Wound Management Ltd(UK)
  • Molnlycke Health Care AB(Sweden)
  • Johnson & Johnson(US)
  • Hollister Incorporated(US)
  • Ethicon, Inc.(US)
  • Acelity LP Inc.(US)
  • Advancis Medical(UK)
  • Coloplast Corporation(US)
  • Medtronic plc(Ireland)
  • Molnlycke Health Care(US)
  • Urgo Medical(France)
  • Medline Industries Ltd.(UK)
  • In May 2023, Kane Biotech Inc.(referred to as Kane Biotech)announced that it had gotten 510(k)freedom from the US Food, Drug Administration(FDA)for its coactiv+(TM)Antimicrobial Injury Gel. This clearance covers the management of ulcers(counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds,, and careful entry points for grown-up populaces.
  • In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM)Antimicrobial Injury Gel(previously known as coactiv+(TM)Antimicrobial Injury Gel).
簡介目錄
Product Code: SQMIG35D2162

Global Moist Wound Dressings market size was valued at USD 4.31 billion in 2022 and is poised to grow from USD 4.53 billion in 2023 to USD 6.80 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).

The global market for moist wound dressings demonstrates robust growth, propelled by the rising focus on advanced wound care and the escalating prevalence of chronic wounds like diabetic ulcers and pressure sores. Healthcare professionals are increasingly embracing moist wound dressings due to their capacity to foster an optimal healing environment, prevent infections, and expedite wound recovery. These dressings offer benefits such as enhanced moisture retention, reduced pain, and improved patient comfort. Furthermore, ongoing research and development endeavors are dedicated to enhancing the effectiveness of moist wound dressings through innovative materials and technologies. With the aging population expanding and healthcare infrastructure advancing globally, the demand for efficient wound management solutions is anticipated to drive the market's growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Moist Wound Dressings Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Moist Wound Dressings Market Segmental Analysis

The global moist wound dressings market is segmented on the basis of Product, Application, End user, and region. By Product, the market is segmented into Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Other Dressings. By Application, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical and Traumatic Wounds, Burns, Others. By End user, the market is segmented into Hospitals, Clinics, Home Healthcare. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Moist Wound Dressings Market

A significant factor driving the global moist wound dressings market is the ongoing progress in wound care technologies and materials. Developments in dressing materials, including hydrocolloids, hydrogels, and foam dressings, have resulted in more efficient and adaptable products that foster optimal wound healing environments. Moreover, the incorporation of antimicrobial agents and the creation of smart dressings capable of monitoring wound conditions are enhancing the therapeutic properties of moist wound dressings. These advancements are leading to increased adoption by healthcare professionals and patients, thereby stimulating market growth.

Restraints in the Global Moist Wound Dressings Market

A significant constraint in the global moist wound dressings market is the stringent regulatory landscape governing medical devices and healthcare products. Adhering to diverse regulatory requirements and securing necessary approvals can be a laborious and expensive endeavor for manufacturers. Moreover, evolving regulations and differing standards across various regions can present hurdles for market expansion and product advancement. Negotiating these regulatory obstacles can slow down the pace of innovation and market entry for moist wound dressing products.

Market Trends of the Global Moist Wound Dressings Market

A significant trend in the global moist wound dressings market is the growing focus on integrating bioactive ingredients into these dressings. Manufacturers are exploring the inclusion of substances such as silver, honey, and growth factors to enhance the therapeutic properties of the dressings. These bioactive additives hold promise in expediting wound healing, lowering infection rates, and enhancing overall patient outcomes. As healthcare providers and patients increasingly seek more efficient and comprehensive wound care solutions, moist dressings with bioactive elements are gaining momentum, signaling a noteworthy transition towards advanced and tailored wound management approaches.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Moist Wound Dressings Market by Product

  • Market Overview
  • Foams
  • Hydrocolloids
  • Semi-Permeable Films
  • Hydrogels
  • Alginates
  • Hydro Fibres and Collagens

Global Moist Wound Dressings Market by Application

  • Market Overview
  • Pressure Ulcers
  • Diabetic Ulcers
  • Burn Wounds
  • Surgical Wounds
  • Traumatic Wounds
  • and Others

Global Moist Wound Dressings Market by End-user

  • Market Overview
  • Hospitals
  • Homecare
  • Clinics
  • and Others

Global Moist Wound Dressings Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • 3M Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Derma Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systagenix Wound Management Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acelity L.P. Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advancis Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urgo Medical (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In May 2023, Kane Biotech Inc. (referred to as Kane Biotech) announced that it had gotten 510(k) freedom from the U.S. Food and Drug Administration (FDA) for its coactiv+(TM) Antimicrobial Injury Gel. This clearance covers the management of ulcers (counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds, and careful entry points for grown-up populaces.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM) Antimicrobial Injury Gel (previously known as coactiv+(TM) Antimicrobial Injury Gel).
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments